Could talk therapy help teens with diabetes? a new pilot study explores DBT for mind and body

NCT ID NCT05107154

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This pilot study tests whether dialectical behavioural therapy (DBT) — a type of talk therapy that teaches skills like mindfulness and emotion regulation — can help Indigenous youth with type 2 diabetes improve their quality of life and diabetes control. The study enrolls 20 youth aged 14–22 and includes traditional medicine elements co-developed with community members. The goal is to see if the approach is feasible and acceptable before planning a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dialectical behavioural therapy (DBT) skills training
What this could lead to
If successful, this approach could provide a culturally tailored mental health tool to help youth with type 2 diabetes better manage their condition and improve quality of life.
What could go wrong
This is a small pilot study (20 participants) focused on feasibility, not effectiveness. The therapy may not produce measurable health improvements, and results may not apply to other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2, CHILDHOOD-ONSET are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinic Y, Health Sciences Centre

    Winnipeg, Manitoba, R3A 1R9, Canada

  • Diabetes Education Resource Centre for Adolescents Clinic, Health Sciences Centre

    Winnipeg, Manitoba, R3A1R9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.